To determine the influence of body fat distribution on kinetic aspects of i
nsulin action, we have monitored the rate of increase of glucose infusion d
uring 6-hour hyperinsulinemic (40 mU/m(2)/min) euglycemic clamps in 10 pati
ents with upper body obesity (body mass index [BMI], 41 +/- 3 kg/m(2); wais
t-to-hip ratio [WHR], > 1.00 for men and > 0.85 for women), 12 patients wit
h lower body obesity (BMI, 40 +/- 2 kg/m(2); WHR, < 1.00 for men and < 0.85
for women), and 5 control subjects (BMI, < 30 kg/m(2); WHR, < 1.00 for men
and < 0.85 for women). In ail subjects, glucose infusion rate (GIR) to mai
ntain euglycemia increased during the clamp studies to achieve maximal, ste
ady state values after the fourth to fifth hour. During the first 2 hours o
f clamp, mean clip (GIR(20-120min)) (traditional approach to assess insulin
sensitivity) was lower (P < 0.05) in the upper body obesity group than in
the lower body obesity group (2.12 +/- 0.14 and 3.03 +/- 0.33 mg/kg per min
, respectively). In contrast, the maximal steady-state GIR (GIR(MAX)) (calc
ulated as mean GIR during the sixth hour of clamp) was similar in the upper
body and in the lower body obesity groups (4.48 +/- 0.45 and 4.57 +/- 0.36
mg/kg per min, respectively). Control subjects exhibited higher values of
both GIR(20-120min) and GIR(MAX) (5.57 +/- 0.67 and 7.05 +/- 0.59 mg/kg per
min, respectively) than those of both groups of obese patients. The time t
o reach half-maximal GIR (T-1/2) was greater (P < .05) in the upper body ob
esity (94 +/- 12 min) than that in the lower body obesity(41 +/- 5 min) and
in the control group (30 +/- 5 min). In pooled subjects, BMI correlated wi
th GIR(MAX) (n = 27, R = -.75, P < .001), but not with T-1/2 (R = .21). Sim
ilarly, whole body percent fat mass, as assessed by bioelectrical impedance
analysis, correlated with GIR(MAX) (n = 16, R = -.79, P < .001), but not w
ith T-1/2 (R = .10). In contrast, WHR closely correlated with T-1/2 (n = 27
, R = .78, P < .001), but not with GIR(MAX) (R = .11). We conclude that upp
er body obesity is associated with a slower rate of activation of insulin a
ction on glucose metabolism, whereas total body adiposity selectively affec
ts the maximal, steady-state insulin effect. Copyright (C) 2001 by W.B. Sau
nders Company.